Ontology highlight
ABSTRACT: Background
Medication adherence is a crucial component in the management of patients with chronic diseases needing a long-term pharmacotherapy. Parkinson's disease (PD) is a chronic, degenerative disease with complex drug treatment that poses challenging barriers to patient adherence. The adoption of best practices of scale development can contribute to generate solid concepts and, in the long run, a more stable knowledge base on the underlying constructs of medication adherence in PD measured by the items of the first scale to be created for this purpose.Purpose
To present the development process and clinimetric testing plan of the Parkinson's Disease Medication Adherence Scale (PD-MAS).Method
We adopted a hybrid approach plan based on the United States Food and Dr
SUBMITTER: Tosin MHS
PROVIDER: S-EPMC9136049 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature